PP2A-Bα Inhibitors

Chemical inhibitors of PP2A-Bα employ a variety of mechanisms to disrupt the regulatory function of the Bα regulatory subunit on the PP2A holoenzyme's phosphatase activity. Cantharidin and norcantharidin inhibit the PP2A-Bα by binding to the enzyme's catalytic subunit, effectively preventing the essential interaction between the Bα regulatory subunit and the PP2A core enzyme. This action blocks the phosphatase activity that is normally modulated by the Bα subunit. Similarly, endothall acts on the catalytic subunit of PP2A, but through a covalent modification, which also impedes the Bα subunit's regulatory role. Another inhibitor, okadaic acid, selectively binds to the PP2A catalytic core, thus obstructing the Bα subunit's association and inhibiting the PP2A complex's activity. Calyculin A operates in a closely related manner, by binding with high affinity to the catalytic subunit and preventing the Bα subunit from exerting its regulatory influence.

In addition, tautomycin targets PP2A-Bα by binding to the catalytic subunit, which inhibits the interaction with the Bα regulatory subunit, thereby reducing the dephosphorylation process under the control of PP2A-Bα. Microcystin-LR and rubratoxin B also inhibit PP2A-Bα, with the former binding covalently to the catalytic subunit and the latter by a not fully understood mechanism that interferes with the enzyme's phosphatase activity, possibly affecting the catalytic subunit's function. LB-100, a small molecule inhibitor, directly targets the catalytic subunit, diminishing the Bα subunit's modulation of PP2A phosphatase activity. Phenothiazines, while known for other primary actions, result in a reduction of PP2A activity, which implies a decreased function of the Bα regulatory subunit. Sanguinarine interacts with the catalytic subunit of PP2A, blocking the effects of the Bα subunit, and fostriecin selectively binds to the catalytic subunit, impeding the Bα subunit's regulatory capacity. These diverse chemical inhibitors, through their unique interactions with PP2A-Bα, demonstrate the intricate control mechanisms that govern PP2A phosphatase activity.